| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/24/2013 | WO2013011063A1 Antagonistic antibodies against oscar |
| 01/24/2013 | WO2013011062A2 Oscar antagonists |
| 01/24/2013 | WO2013011061A1 Antagonistic antibodies against oscar |
| 01/24/2013 | WO2013011059A1 Antagonist antibodies against oscar |
| 01/24/2013 | WO2013011030A1 Human monoclonal antibody against the gamma subunit of the acetylcholine receptor for use in the treatment of rhabdomyosarcoma. |
| 01/24/2013 | WO2013011021A1 Use of c-fms antagonists |
| 01/24/2013 | WO2013010955A1 Antibodies that are cross-reactive for macrophage migration inhibitory factor (mif) and d-dopachrome tautomerase (d-dt) |
| 01/24/2013 | WO2013010812A1 Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof |
| 01/24/2013 | WO2013010749A1 Sequential anti - ctla4 and targeted il-2 therapy |
| 01/24/2013 | WO2013010537A1 Method of treating morphea |
| 01/24/2013 | WO2013010260A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 01/24/2013 | WO2012163520A4 Dual targeting |
| 01/24/2013 | US20130024956 Antibodies to cd40 |
| 01/24/2013 | US20130023654 Antibodies to matrix metalloproteinase 9 |
| 01/24/2013 | US20130023653 Tissue Specific Expression Of Antibodies In Chickens |
| 01/24/2013 | US20130023652 Humanization of rabbit antibodies using a universal antibody framework |
| 01/24/2013 | US20130023651 Peptides for treatment and diagnosis of bone diseases |
| 01/24/2013 | US20130023647 Modified human thymic stromal lymphopoietin |
| 01/24/2013 | US20130023565 Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use |
| 01/24/2013 | US20130023435 Sers-based analyte detection |
| 01/24/2013 | US20130022997 Monoclonal antibody against pbp2a derived from mrsa with dual binding activities |
| 01/24/2013 | US20130022983 Colon and Rectal Tumor Markers and Methods of Use Thereof |
| 01/24/2013 | US20130022982 Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury |
| 01/24/2013 | US20130022981 Novel human lysosomal protein and methods of its use |
| 01/24/2013 | US20130022669 Branched, compact polyethyleneglycol derivatives |
| 01/24/2013 | US20130022625 Stabilized Antibody-Containing Liquid Formulations |
| 01/24/2013 | US20130022624 Anti-epidermal growth factor receptor antibodies and uses thereof |
| 01/24/2013 | US20130022623 Antibodies that specifically bind to tim3 |
| 01/24/2013 | US20130022619 Methods and compositions for inhibiting hiv transmission |
| 01/24/2013 | US20130022618 Human cytomegalovirus neutralizing antibodies and use thereof |
| 01/24/2013 | US20130022616 Interleukin-31 Monoclonal Antibody |
| 01/24/2013 | US20130022614 IgE ANTIBODIES FOR THE TREATMENT OF CANCER |
| 01/24/2013 | US20130022612 Methods and compositions for malaria prophylaxis |
| 01/24/2013 | US20130022611 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 01/24/2013 | US20130022608 FULL-LENGTH IgG IMMUNOGLOBULINS CAPABLE OF RECOGNIZING A HETEROSUBTYPE NEUTRALIZING EPITOPE ON THE HEMAGGLUTININ STEM REGION AND USES THEREOF |
| 01/24/2013 | US20130022607 Mucosal vascular addressins and uses thereof |
| 01/24/2013 | US20130022606 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/24/2013 | US20130022605 Antagonists against tnfr1 and methods of use therefor |
| 01/24/2013 | US20130022604 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa |
| 01/24/2013 | US20130022603 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa |
| 01/24/2013 | US20130022601 Trivalent, bispecific antibodies |
| 01/24/2013 | US20130022598 Dual Specific Immunotoxin for Brain Tumor Therapy |
| 01/24/2013 | US20130022597 Antibodies Directed To GPNMB And Uses Thereof |
| 01/24/2013 | US20130022595 Variants of humanized immunomodulatory monoclonal antibodies |
| 01/24/2013 | US20130022544 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
| 01/24/2013 | US20130022539 Ovr115 antibody compositions and methods of use |
| 01/24/2013 | CA2842475A1 Interleukin-31 monoclonal antibody |
| 01/24/2013 | CA2842345A1 Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
| 01/24/2013 | CA2842180A1 Methods and compositions for inhibiting polyomavirus-associated pathology |
| 01/24/2013 | CA2842169A1 Anti-cxcr4 antibodies and methods of use |
| 01/24/2013 | CA2842068A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 01/24/2013 | CA2841745A1 Rspo binding agents and uses thereof |
| 01/24/2013 | CA2841725A1 Anti-folate receptor alpha antibodies and uses thereof |
| 01/24/2013 | CA2841551A1 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 01/24/2013 | CA2841105A1 Antigen-binding proteins with increased fcrn binding |
| 01/24/2013 | CA2841093A1 Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof |
| 01/24/2013 | CA2841013A1 Use of c-fms antagonists |
| 01/23/2013 | EP2548892A1 Inhibitory anti-Factor XII/XIIa monoclonal Antibodies and their uses |
| 01/23/2013 | EP2548891A1 Human monoclonal antibody against the gamma subunit of the acetylcholine receptor for use in the treatment of rhabdomyosarcoma. |
| 01/23/2013 | EP2548890A1 Anti MIF antibodies |
| 01/23/2013 | EP2548889A1 Antibodies against human interleukin-13 and uses thereof |
| 01/23/2013 | EP2548888A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 01/23/2013 | EP2548583A2 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| 01/23/2013 | EP2548579A1 Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases |
| 01/23/2013 | EP2548578A1 Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases |
| 01/23/2013 | EP2548577A1 Human anti-il-23 antibodies, compositions, methods and uses |
| 01/23/2013 | EP2548575A1 Anti-CD19 antibodies that mediate ADCC for use in treating autoimmune diseases |
| 01/23/2013 | EP2548025A2 Using phage epitopes to profile the immune response |
| 01/23/2013 | EP2547781A1 Method of producing transcripts using cryptic splice sites |
| 01/23/2013 | EP2547700A1 Peptides or antibodies which bind to melanoma inhibitory activity (mia) protein |
| 01/23/2013 | EP2547365A1 Anti-nerve growth factor (ngf) antibody compositions |
| 01/23/2013 | EP2547364A1 Peptides, conjugates and method for increasing immunogenicity of a vaccine |
| 01/23/2013 | EP2547363A2 Methods of prevention or treatment of triggered inflammatory reactions using tumor necrosis factor alpha antagonist |
| 01/23/2013 | EP2261375B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 01/23/2013 | CN102893154A Compositions and methods for detecting cancer |
| 01/23/2013 | CN102892885A Iga-binding peptide and iga purification using same |
| 01/23/2013 | CN102892787A Radioactive metal-labeled anti-cadherin antibody |
| 01/23/2013 | CN102892786A Pd-1抗体 Pd-1 antibody |
| 01/23/2013 | CN102892785A Biological products: humanised agonistic anti-pd-1 antibodies |
| 01/23/2013 | CN102892784A Methods for treating breast cancer |
| 01/23/2013 | CN102892783A Method of inducing production of protective anti-hiv-1 antibodie |
| 01/23/2013 | CN102892782A Binding members for human cytomegalovirus |
| 01/23/2013 | CN102892774A Method of functionalizing human red blood cells with antibody |
| 01/23/2013 | CN102892432A Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis |
| 01/23/2013 | CN102892431A Peptides, conjugates and method for increasing immunogenicity of a vaccine |
| 01/23/2013 | CN102892430A Anti-nerve growth factor (ngf) antibody compositions |
| 01/23/2013 | CN102892426A Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof |
| 01/23/2013 | CN102888658A Murine human colorectal cancer-resistant Fab phage antibody library and construction method thereof |
| 01/23/2013 | CN102887955A Purified antibody composition |
| 01/23/2013 | CN102887954A Human anti-il-23 antibodies, compositions, methods and uses |
| 01/23/2013 | CN102887953A Anti-abeta antibodies and their use |
| 01/23/2013 | CN102887952A Monoclonal antibody against pbp2a derived from mrsa with dual binding activities |
| 01/23/2013 | CN102887943A B cell epitope peptide segment of amino-terminal pro-brain natriuretic peptide and applications thereof |
| 01/23/2013 | CN102417895B Monoclonal antibody for beta-conglycinin beta-subunit and application of monoclonal antibody |
| 01/23/2013 | CN101885774B Methandienone monoclonal antibody, preparation method and application thereof |
| 01/23/2013 | CN101210244B Neutrokine-alpha and Neutrokine-alpha splice variants |
| 01/23/2013 | CN101193914B Antibodies directed against amyloid-beta peptide and methods using same |
| 01/22/2013 | US8357792 SRSV detection kit |
| 01/22/2013 | US8357791 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 01/22/2013 | US8357789 comprising an RNA sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells |